TF and Parkinson disease: Thus, our data suggest that changes in the level of catecholamines and the activity of α-2-macroglobulin in the TF can be considered as potential biomarkers for a differential and preclinical diagnosis of PD, and the lacrimal glands can be regarded as one of the possible sources of catecholamine in the TF.